Sign in
RAPT Stock Price, Chart, Stats & News
RAPT Therapeutics, Inc.
Save
RAPT Therapeutics, Inc. (RAPT) does not currently pay a dividend.
1.61B
Market cap
–
Current P/E
–
Forward P/E
RAPT chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -63.74% |
ROE | -61.81% |
D/E | 0.02x |
Interest coverage ratio | – |
RAPT valuation
P/E | – |
P/S | – |
P/B | 10.29x |
P/CF | -18.06x |
P/FCF | -11.07x |
P/OCF | -18.06x |
PEG | -0.67x |
EV multiple | -9.21x |
About
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies. These treatments are aimed at addressing critical unmet medical needs for patients battling oncology and inflammatory diseases.
Similar securities
Based on sector and market capitalization
Report issue